Skip to Main Content

Advertisement

Skip Nav Destination

Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer

Cancer Res (2023) 83 (18): 3145–3158.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Alejandro Falcón González
  • Josefina Cruz Jurado
  • Elisenda Llabrés Valenti
  • Rocío Urbano Cubero
  • Maria Carmen Álamo de la Gala
  • María Antonia Martínez Guisado
  • Rocío Álvarez Ambite
  • Carlos José Rodríguez González
  • Marta Amérigo Góngora
  • Lourdes Rodríguez Pérez
  • Pilar López Álvarez
  • Pedro Sánchez Rovira
  • Encarnación González Flores
  • Fernando Henao Carrasco
  • Juan Bayo Calero
  • María Valero Arbizu
  • Alicia Quílez Cutillas
  • Javier Salvador Boffil
  • Eloísa Rubio Pérez
  • Manuel Ruiz-Borrego
Clinical and Translational Oncology (2024) 26 (9): 2217.
  • Ciprian Tomuleasa
  • Adrian-Bogdan Tigu
  • Raluca Munteanu
  • Cristian-Silviu Moldovan
  • David Kegyes
  • Anca Onaciu
  • Diana Gulei
  • Gabriel Ghiaur
  • Hermann Einsele
  • Carlo M. Croce
Signal Transduction and Targeted Therapy (2024) 9 (1)
  • Mason S. Lacy
  • Adrianne L. Jenner
Bulletin of Mathematical Biology (2024) 86 (4)
  • Yucheng Tian
  • Kang Liu
  • Dongdong Wu
  • Liuyi Wu
  • Qianqian Xu
  • Wei Wei
  • Zhiyu Li
  • Qianming Du
  • Jinlei Bian
European Journal of Medicinal Chemistry (2024) 268: 116275.
  • Junjie Shen
  • Shuo Wang
  • Hao Sun
  • Jie Huang
  • Lu Bai
  • Xichao Wang
  • Yongfei Dong
  • Zaixiang Tang
BMC Medical Research Methodology (2024) 24 (1)
  • Chao Yang
  • Wenwen Zhang
  • Shi Xiang
  • Lai Chen
  • Jiong Chun
  • Hui Chen
BMC Complementary Medicine and Therapies (2024) 24 (1)
Close Modal

or Create an Account

Close Modal
Close Modal